Kevin S. Harris
Corporate Officer/Principal presso American Society for Virology
Profilo
Kevin Harris is Virology Director of Koronis Pharmaceuticals, Inc. and a Member of the American Society for Virology.
Prior to joining Koronis Pharmaceuticals, he was a Senior Molecular Biologist at Abbott Laboratories.
Dr. Harris received a PhD from SUNY Stony Brook in 1994.
Posizioni attive di Kevin S. Harris
| Società | Posizione | Inizio |
|---|---|---|
| American Society for Virology | Corporate Officer/Principal | 17/04/2009 |
Precedenti posizioni note di Kevin S. Harris
| Società | Posizione | Fine |
|---|---|---|
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Koronis Pharmaceuticals, Inc.
 Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formazione di Kevin S. Harris
| Stony Brook University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Aziende private | 2 |
|---|---|
Koronis Pharmaceuticals, Inc.
Koronis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Koronis Pharmaceuticals, Inc. develops antiviral therapeutics based on viral decay acceleration. Its therapeutics are designed to inhibit a specific viral protein or enzyme, drugs based on VDA are designed to provoke the rapid decay of the targeted virus by further increasing its naturally high rate of mutation. The company was founded by Richard Daifuku in 1998 and is headquartered in Seattle, WA. | Health Technology |
| American Society for Virology |
- Borsa valori
- Insiders
- Kevin S. Harris
